2023 - Research.com Biology and Biochemistry in Australia Leader Award
Ian J. Stratford mainly focuses on Cancer research, Radiation therapy, Biochemistry, In vivo and In vitro. Ian J. Stratford has included themes like Hypoxia, Gene expression, Chemotherapy, Immunology and Cancer therapy in his Cancer research study. The concepts of his Hypoxia study are interwoven with issues in Molecular biology, Transcription factor and Pathology.
His Radiation therapy research integrates issues from Cancer and Immune system. His Biochemistry research is multidisciplinary, incorporating perspectives in Cell culture and Toxicity. His studies in In vivo integrate themes in fields like Endocrinology, Radiosensitivity, Internal medicine, Angiogenesis and Glycolysis.
His scientific interests lie mostly in Cancer research, Pharmacology, Biochemistry, In vitro and Hypoxia. His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Immunology, Pathology, Genetic enhancement and Radiation therapy. His study looks at the relationship between Pharmacology and fields such as Misonidazole, as well as how they intersect with chemical problems.
He interconnects Toxicity and In vivo in the investigation of issues within In vitro. The various areas that Ian J. Stratford examines in his Hypoxia study include Carcinoma and Chemotherapy. Ian J. Stratford usually deals with Cytotoxicity and limits it to topics linked to Cell culture and Molecular biology.
His primary areas of study are Cancer research, Cancer, Radiation therapy, Internal medicine and Stereochemistry. His research in Cancer research intersects with topics in Cell culture, Radiosensitivity, Cancer cell, Monocarboxylate transporter and In vivo. As part of the same scientific family, Ian J. Stratford usually focuses on Cancer, concentrating on Hyaluronic acid and intersecting with Gene isoform and Cell.
His studies in Radiation therapy integrate themes in fields like Agonist, Immunology, Immune system and Pathology. The various areas that he examines in his Internal medicine study include Endocrinology and Oncology. His Stereochemistry research incorporates themes from Combinatorial chemistry, Anti tumour, Quinone oxidoreductase and Enzyme.
Cancer research, Biochemistry, Radiation therapy, Cancer and Hyaluronic acid are his primary areas of study. His biological study spans a wide range of topics, including Radiosensitivity, Cancer cell, Glycolysis, Monocarboxylate transporter 1 and In vivo. His work carried out in the field of Radiosensitivity brings together such families of science as Cell culture, Tumor hypoxia, Tumor Oxygenation and Pathology.
His Radiation therapy study incorporates themes from Immune system and Immunology. His research integrates issues of Clinical trial and Transplantation in his study of Cancer. His study on Hyaluronic acid also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.
P H Maxwell;G U Dachs;J M Gleadle;L G Nicholls.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Guidelines for the welfare and use of animals in cancer research
P Workman;E O Aboagye;F Balkwill;A Balmain.
British Journal of Cancer (2010)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi;Amy L. Adlard;Grazyna Lipowska-Bhalla;Conor McKenna.
Cancer Research (2014)
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
Juliette A. Loncaster;Adrian L. Harris;Susan E. Davidson;John P. Logue.
Cancer Research (2001)
Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361
Christopher R. Calabrese;Robert Almassy;Stephanie Barton;Michael A. Batey.
Journal of the National Cancer Institute (2004)
Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.
G. E. Adams;I. R. Flockhart;C. E. Smithen;I. J. Stratford.
Radiation Research (1976)
Targeting gene expression to hypoxic tumor cells.
G.U Dachs;Aa.V Patterson;Aa.V Patterson;J.D Firth;P.J Ratcliffe.
Nature Medicine (1997)
Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.
Janine T Erler;Christopher Cawthorne;Kaye J Williams;Marianne Koritzinsky.
Molecular and Cellular Biology (2004)
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
R Airley;Juliette A Loncaster;Susan E Davidson;Michael Bromley.
Clinical Cancer Research (2001)
Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency
G.E. Adams;E.D. Clarke;I.R. Flockhart;R.S. Jacobs.
International Journal of Radiation Biology (1979)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Oxford
University of Manchester
Italian Institute of Technology
University of Manchester
The Francis Crick Institute
Institute of Cancer Research
University of Manchester
University of Oxford
University of Nottingham
Mount Vernon Hospital
Toyohashi University of Technology
University of Kentucky
University of Montpellier
University of Aberdeen
University of Los Lagos
University of California, Davis
National Academies of Sciences, Engineering, and Medicine
Environment and Climate Change Canada
University of Gothenburg
Oswaldo Cruz Foundation
Stanford University
Leiden University Medical Center
Columbia University
Vanderbilt University Medical Center
National Institutes of Health
University of Michigan–Ann Arbor